Literature DB >> 6288505

Diagnostic ability of hepatobiliary scintigraphy.

I Takeda, S Nakano, H Watahiki.   

Abstract

Morphological aspects of biliary images were observed by the hepatobiliary scintigraphy using 99mTc-PI (pyridoxylidene isoleucine). Our study was made mainly on the diagnostic ability of the scintigram in various hepatobiliary diseases. Diagnostic findings were observed in 53.8% of the cases with intrahepatic stones and all cases with cholangioma. In the stone of the common bile duct and extrahepatic biliary cancer, the diagnostic findings were observed in 42.3% and 37.5% respectively. Hepatobiliary scintigraphy was less reliable for the diagnosis of the lesions in the gallbladder. The findings by hepatobiliary scintigraphy were as same as those by X-ray basically. In the cases showing the diagnostic finding by hepatobiliary scintigraphy, it seems to be possible to distinguish the stone from the cancer. Contrary to X-ray picture, scintigram is inferior in the image. So, it is necessary to perform ERCP or PTC to investigate fully the hepatobiliary lesions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288505     DOI: 10.1007/bf02775996

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  6 in total

1.  [Clinical evaluation of hepatobiliary scintigraphy using 99mTc-pyridoxylideneisoleucine (author's transl)].

Authors:  T Kashiwagi; K Kimura; H Fusamoto; T Suematsu; M Schichiri; T Kamada; H Abe
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1979-04

2.  Hepatobiliary radiopharmaceuticals: defining their clinical role will be a galling experience.

Authors:  P M Ronai
Journal:  J Nucl Med       Date:  1977-05       Impact factor: 10.057

3.  Tc-99m(Sn) pyridoxylideneaminates: preparation and biologic evaluation.

Authors:  M Kato; M Hazue
Journal:  J Nucl Med       Date:  1978-04       Impact factor: 10.057

4.  Technetium-99m pyridoxylideneglutamate (P.G.) cholescintigraphy.

Authors:  R C Stadalnik; N M Matolo; A L Jansholt; K A Krohn; G L DeNardo; E F Wolfman
Journal:  Radiology       Date:  1976-12       Impact factor: 11.105

5.  [The hepato-biliary scan using 99mTc-pyridoxylidene isoleucine (99mTc-PI) and its clinical significance (author's transl)].

Authors:  S Nakano; H Watahiki; I Takeda; K Kitamura; H Ichikawa; I Kanamori; T Kimura; T Sasaki
Journal:  Kaku Igaku       Date:  1978-05

6.  [99mTc-(Sn)-pyridoxylidenevaline and 99mTc-(Sn)-pyridoxylideneisoleucine: potential radiopharmaceuticals for hepatobiliary tract imaging].

Authors:  M Kato; M Hazue
Journal:  Kaku Igaku       Date:  1977-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.